Almirall and Microsoft partner on AI-powered drug discovery in dermatology

Almirall S.A., a global pharmaceutical company focused on medical dermatology, announced today a strategic partnership with Microsoft to drive innovation and digital transformation, advance the research of medical solutions for dermatological diseases, and accelerate the digital transformation of the company.

Signal: British biopharma applies for BLA for T-cell cancer therapy – Pharmaceutical Technology

Share this article Acute lymphoblastic leukaemia seen in human blood. Illustration: Science Photo Library/Getty Images. British biopharmaceuticals company Autolus Therapeutics has submitted a Biologics License

November 27, 2023

J&J’s dealmaker: Plenty of ‘firepower,’ but mostly focused on tuck-in M&A

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 7, 2024

Wearable ultrasound device could detect breast cancer in early stages

When breast cancer is diagnosed in the earliest stages, the survival rate is nearly 100 percent. However, for tumors detected in later stages, that rate

July 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.